GEMVAX&KAEL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,830 KRW | +1.28% |
|
+6.77% | -10.92% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 421,594 | 1,478,634 | 943,346 | 694,507 | 465,482 | 523,463 |
| Enterprise Value (EV) 1 | 386,408 | 1,423,619 | 897,922 | 667,227 | 430,110 | 517,306 |
| P/E ratio | -28.8 x | -15 x | -147 x | 62.6 x | -23.1 x | -19.2 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 8.92 x | 34.7 x | 14.4 x | 11.5 x | 6.14 x | 7.25 x |
| EV / Revenue | 8.18 x | 33.4 x | 13.7 x | 11.1 x | 5.67 x | 7.16 x |
| EV / EBITDA | -80.8 x | -241 x | 535 x | -4,926 x | -483 x | -133 x |
| EV / FCF | 67.4 x | 85 x | -48.7 x | -63.1 x | -42.9 x | -173 x |
| FCF Yield | 1.48% | 1.18% | -2.05% | -1.58% | -2.33% | -0.58% |
| Price to Book | 3.7 x | 15.6 x | 6.98 x | 4.51 x | 3.46 x | 4.85 x |
| Nbr of stocks (in thousands) | 35,133 | 38,356 | 39,471 | 39,686 | 39,281 | 39,417 |
| Reference price 2 | 12,000 | 38,550 | 23,900 | 17,500 | 11,850 | 13,280 |
| Announcement Date | 3/21/19 | 3/19/20 | 3/23/21 | 3/23/22 | 3/22/23 | 3/21/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 47,240 | 42,664 | 65,663 | 60,371 | 75,804 | 72,209 |
| EBITDA 1 | -4,780 | -5,897 | 1,678 | -135.4 | -890.5 | -3,877 |
| EBIT 1 | -6,623 | -7,578 | -40.62 | -2,450 | -3,929 | -7,868 |
| Operating Margin | -14.02% | -17.76% | -0.06% | -4.06% | -5.18% | -10.9% |
| Earnings before Tax (EBT) 1 | -13,565 | -92,103 | 1,635 | 12,058 | -19,604 | -27,348 |
| Net income 1 | -13,705 | -92,103 | 1,635 | 12,058 | -19,604 | -27,177 |
| Net margin | -29.01% | -215.88% | 2.49% | 19.97% | -25.86% | -37.64% |
| EPS 2 | -417.3 | -2,562 | -162.4 | 279.6 | -512.2 | -691.0 |
| Free Cash Flow 1 | 5,733 | 16,747 | -18,429 | -10,569 | -10,016 | -2,996 |
| FCF margin | 12.14% | 39.25% | -28.07% | -17.51% | -13.21% | -4.15% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/21/19 | 3/19/20 | 3/23/21 | 3/23/22 | 3/22/23 | 3/21/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 35,187 | 55,015 | 45,424 | 27,280 | 35,372 | 6,157 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 5,733 | 16,747 | -18,429 | -10,569 | -10,016 | -2,996 |
| ROE (net income / shareholders' equity) | -15.2% | -88.2% | 1.44% | 8.34% | -13.6% | -22.4% |
| ROA (Net income/ Total Assets) | -2.49% | -2.82% | -0.02% | -0.92% | -1.52% | -3.44% |
| Assets 1 | 550,318 | 3,264,786 | -10,283,046 | -1,303,837 | 1,291,079 | 791,099 |
| Book Value Per Share 2 | 3,239 | 2,476 | 3,425 | 3,880 | 3,420 | 2,740 |
| Cash Flow per Share 2 | 1,009 | 1,443 | 1,286 | 472.0 | 402.0 | 419.0 |
| Capex 1 | 760 | 905 | 10,374 | 6,874 | 9,090 | 8,461 |
| Capex / Sales | 1.61% | 2.12% | 15.8% | 11.39% | 11.99% | 11.72% |
| Announcement Date | 3/21/19 | 3/19/20 | 3/23/21 | 3/23/22 | 3/22/23 | 3/21/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -10.92% | 337M | |
| +67.61% | 2,127B | |
| +33.22% | 628B | |
| +11.34% | 603B | |
| -2.18% | 256B | |
| +2.76% | 161B | |
| -39.59% | 130B | |
| +28.60% | 125B | |
| +26.87% | 104B | |
| -2.31% | 99.48B |
- Stock Market
- Equities
- A082270 Stock
- Financials GemVax&KAEL Co.,Ltd.
